VENETOCLAX

62878 reported adverse events

Drug classes: BCL-2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking VENETOCLAX:

# Side effect Count
0 DEATH 10347
1 OFF LABEL USE 7028
2 NEUTROPENIA 3635
3 FEBRILE NEUTROPENIA 3178
4 MYELOSUPPRESSION 3045
5 PLATELET COUNT DECREASED 2936
6 PYREXIA 2849
7 PNEUMONIA 2733
8 FATIGUE 2723
9 DIARRHOEA 2438
See all common reactions for VENETOCLAX

VENETOCLAX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALLOGENIC STEM CELL TRANSPLANTATION 85 0.5380
1 ACUTE MYELOID LEUKAEMIA REFRACTORY 76 0.4419
2 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 33 0.3708
3 PLATELET TRANSFUSION 401 0.3113
4 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 211 0.3027
5 T-CELL PROLYMPHOCYTIC LEUKAEMIA 28 0.3011
6 ACUTE MYELOID LEUKAEMIA RECURRENT 615 0.2862
7 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 23 0.2840
8 ASPIRATION BONE MARROW 36 0.2707
9 PROTOTHECOSIS 25 0.2660
See all enriched reactions for VENETOCLAX